Перевести на Переведено сервисом «Яндекс.Перевод»

Pluristem Therapeutics

Country
Israel
Краткое название
Pluristem Therapeutics
Headquarters
MATAM Advanced Technology Park Building No. 20
Members of the board

Zami Aberman,
Chairman & CEO
Yaky Yanay,
VP Finance & CFO
Efrat Livne Hadass,
VP Human Resources
William R. Prather RPh, MD,
Senior VP Corporate Development
Ayelet Chajut, Ph.D.,
VP Research
Ohad Karnieli,
VP Development
David Shoshani, MD,
VP Clinical Affairs
Arie Lahav,
VP Operations
Liat Flaishon, MD, PhD,
Business Development Director
Racheli Ofir, Ph.D.,
Director of Intellectual Property & Senior Scientist
Ronit Monin,
Director of Regulatory Affairs
Daya Lettvin,
Director of Investor & Media Relations

Categories medicine
Cardiology, Infectious diseases
Stage of the project
Production
Disease
Influenza, Ischemic heart disease
Ticker
PSTI
Current owners

Zami Aberman,
Chairman & CEO
Mark Germain
Hava Klemperer Meretzki
Doron Shorre
Isaac Braun
Israel Ben Yoram
Nachum Rosman
Moria Kwiat

Assets
182.3900
Technology
Technologies, Pharmaceuticals, Chemistry